Target intelligence / Profile preview

Ribosomal protein S15a pseudogene

Molecular classification
Pseudogene, Not a member of any canonical functional gene family
01

Overview

This entry represents a **pseudogene** similar to the ribosomal protein S15a gene, meaning it is a DNA sequence that was derived from the functional RPS15A gene but has accumulated mutations (such as frameshifts or stop codons) rendering it *incapable of producing a functional protein product*[2][5]. Pseudogenes are typically classified as “processed” if they arose via retrotransposition, or “non-processed” if they arose from duplication followed by mutation[2][5][8]. While pseudogenes are common in the human genome and generally considered nonfunctional, a minority have regulatory roles at the RNA level, such as acting as competitive endogenous RNAs in cancer, but there is no evidence that this specific pseudogene (ENSG00000235182) plays a direct biological or therapeutic role[9]. In summary, ENSG00000235182 is a **non-functional pseudogene** similar to ribosomal protein S15a. It is not a valid therapeutic or research target, does not encode a protein, and is mainly of genomic interest rather than clinical or pharmacological relevance[2][5][6].

Other names
RPS15A pseudogeneribosomal protein S15a pseudogene
02

Mechanism of action

None

03

Biological functions

Pseudogenes are largely considered non-functional in terms of protein coding.Some pseudogenes, under specific circumstances, can have limited regulatory functions, e.g., acting as competitive endogenous RNAs (ceRNAs) for their parent genes or influencing gene expression via miRNA sponging or non-coding RNA pathways, but these are rare exceptions and not expected for the majority of pseudogenes.
04

Disease associations

None (no direct disease association or mechanism)If the parent gene (RPS15A) were involved, it would be associated with Diamond-Blackfan anemia and possibly cancer via gene expression regulation, but pseudogenes per se are not established as direct disease drivers.
05

Safety considerations

None specific, as pseudogenes do not encode proteins or have recognized functional activities

Beyond the preview

Go deeper on Ribosomal protein S15a pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S15a pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call